Published in J Virol on March 10, 2010
Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell (2014) 1.58
A novel immunity system for bacterial nucleic acid degrading toxins and its recruitment in various eukaryotic and DNA viral systems. Nucleic Acids Res (2011) 1.41
A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J Virol (2012) 1.07
Quantitative proteomic analyses of human cytomegalovirus-induced restructuring of endoplasmic reticulum-mitochondrial contacts at late times of infection. Mol Cell Proteomics (2011) 1.02
The human cytomegalovirus protein UL37 exon 1 associates with internal lipid rafts. J Virol (2010) 0.96
Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J Biol Chem (2015) 0.93
Necroptosis: The Trojan horse in cell autonomous antiviral host defense. Virology (2015) 0.91
Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway. PLoS Pathog (2015) 0.91
Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity. J Virol (2012) 0.85
Prevention of cellular suicide by cytomegaloviruses. Viruses (2012) 0.84
Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. PLoS Pathog (2012) 0.84
Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells. J Virol (2014) 0.84
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol (2014) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
Diverse mechanisms evolved by DNA viruses to inhibit early host defenses. Crit Rev Biochem Mol Biol (2016) 0.78
The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. J Gen Virol (2016) 0.77
Deficiencies in Cellular Processes Modulated by the Retinoblastoma Protein Do Not Account for Reduced Human Cytomegalovirus Replication in Its Absence. J Virol (2015) 0.76
UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene. Front Cell Infect Microbiol (2017) 0.75
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol (2016) 0.75
Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation. Immunol Cell Biol (2016) 0.75
Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus. Viruses (2017) 0.75
Cytomegalovirus, Macrophages and Breast Cancer. Open Virol J (2017) 0.75
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer (1980) 10.11
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res (1982) 4.98
Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol (2001) 4.61
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol (2001) 3.50
Caspases in cell survival, proliferation and differentiation. Cell Death Differ (2006) 3.39
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia (1991) 3.13
Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol (2004) 3.09
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Host defense, viruses and apoptosis. Cell Death Differ (2001) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol (1994) 2.68
Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev (2000) 2.48
Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J Virol (1993) 2.42
Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol (2005) 2.25
Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol (1996) 2.22
Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis (2006) 2.20
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol (1988) 2.01
FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med (1999) 1.92
Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol (2008) 1.90
Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe (2008) 1.85
Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood (2002) 1.84
Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology (1991) 1.83
Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett (1999) 1.83
Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A (2008) 1.82
Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J Virol (1991) 1.81
Human cytomegalovirus UL36 protein is dispensable for viral replication in cultured cells. J Virol (1999) 1.80
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem (2008) 1.78
Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ (1989) 1.70
Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol (2004) 1.66
Role of proteolysis in caspase-8 activation and stabilization. Biochemistry (2007) 1.64
Human cytomegalovirus UL38 protein blocks apoptosis. J Virol (2007) 1.55
Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol (2002) 1.52
Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol (2008) 1.48
Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood (2006) 1.48
Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol (2004) 1.48
Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol (1997) 1.48
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Caspase-independent cell deaths. Curr Opin Cell Biol (2002) 1.46
A 15-kilobase-pair region of the human cytomegalovirus genome which includes US1 through US13 is dispensable for growth in cell culture. J Virol (1991) 1.45
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol (2006) 1.42
Vital functions for lethal caspases. Oncogene (2005) 1.40
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol (2005) 1.37
A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb (2004) 1.34
Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J Virol (2003) 1.28
Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol (2003) 1.27
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood (1996) 1.26
Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene (2006) 1.22
Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res (1996) 1.21
Life's smile, death's grin: vital functions of apoptosis-executing proteins. Curr Opin Cell Biol (2004) 1.20
Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol (2001) 1.18
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Mammalian initiator apoptotic caspases. FEBS J (2005) 1.13
Cell death suppression by cytomegaloviruses. Apoptosis (2005) 1.13
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett (2008) 1.06
Ectopic expression of HCMV IE72 and IE86 proteins is sufficient to induce early gene expression but not production of infectious virus in undifferentiated promonocytic THP-1 cells. Virology (2007) 1.03
RNA analysis and isolation of cDNAs derived from the human cytomegalovirus immediate-early region at 0.24 map units. Intervirology (1990) 1.03
Control of apoptosis by human cytomegalovirus. Curr Top Microbiol Immunol (2008) 1.01
Bifunctional protein conferring enhanced green fluorescence and puromycin resistance. Biotechniques (2001) 1.01
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins. Cell Death Differ (2009) 0.98
Selective permissiveness of TPA differentiated THP-1 myelomonocytic cells for human cytomegalovirus strains AD169 and Towne. Microb Pathog (1994) 0.98
Virally mediated inhibition of Bax in leukocytes promotes dissemination of murine cytomegalovirus. Cell Death Differ (2008) 0.97
Increased monokines in cytomegalovirus infected myelomonocytic cell cultures. Microb Pathog (1989) 0.96
Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells. Microb Pathog (2005) 0.95
Factors affecting human cytomegalovirus gene expression in human monocyte cell lines. Mol Cells (1999) 0.94
Caspase-containing complexes in the regulation of cell death and inflammation. Biol Chem (2006) 0.94
Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ (2004) 0.92
A role for caspases in the differentiation of erythroid cells and macrophages. Biochimie (2007) 0.87
Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages. J Med Virol (2005) 0.86
Convergence of RNA cis elements and cellular polyadenylation factors in the regulation of human cytomegalovirus UL37 exon 1 unspliced RNA production. J Virol (2003) 0.86
Detection of human cytomegalovirus DNA in peripheral blood leukocytes by the polymerase chain reaction. Transfusion (1993) 0.83
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Human cytomegalovirus induces apoptosis in promonocyte THP-1 cells but not in promyeloid HL-60 cells. Virus Res (2003) 0.76
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J Virol (2006) 1.62
Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol (2004) 1.60
Probing the spatial organization of measles virus fusion complexes. J Virol (2009) 1.50
Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol (2005) 1.30
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol (2014) 0.99
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals. AIDS Res Hum Retroviruses (2008) 0.76